Cibus (CBUS) Receivables (2016 - 2026)
Cibus (CBUS) posted Receivables of $703000.0 for Q4 2025, little changed sequentially from $704000.0 in Q3 2025, and down 32.47% YoY from $1.0 million in Q4 2024.
Cibus (CBUS) Receivables (2016 - 2026) Analysis & Trends
Cibus has reported Receivables for 9 years, with the latest figure at $703000.0 in Q4 2025.
- Quarterly Receivables fell 32.47% year-over-year to $703000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $703000.0 (down 32.47% YoY) and the FY2025 annual result came in at $703000.0, down 32.47% from the prior year.
- Receivables was little changed at $703000.0 in Q4 2025 per CBUS's latest filing, from $704000.0 in the prior quarter.
- Over five years, Receivables peaked at $3.8 million in Q2 2021 and troughed at $206000.0 in Q3 2021.
- A 4-year average of $1.1 million and a median of $904000.0 in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2024: Receivables plunged 91.54% in 2021, then soared 130.36% in 2024.
- Over 4 years, Receivables stood at $206000.0 in 2021, then jumped by 254.37% to $730000.0 in 2023, then surged by 42.6% to $1.0 million in 2024, then slumped by 32.47% to $703000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $703000.0, $704000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Dec 31, 2025 | 703,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 950,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 850,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Sep 30, 2023 | 560,000.00 |
| Jun 30, 2023 | 858,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 3.82 Mn |
| Mar 31, 2021 | 1.35 Mn |
| Dec 31, 2020 | 4.89 Mn |
| Sep 30, 2020 | 2.43 Mn |
| Jun 30, 2020 | 2.41 Mn |
| Mar 31, 2020 | 848,000.00 |
| Dec 31, 2019 | 1.09 Mn |